AOH1996 for the Treatment of Refractory Solid Tumors

Summary

This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1996 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2022-08-12

Primary completion

2029-09-13

Completion

2029-09-13

Drugs

Indications